Insiders · EFTR

EFTR insider transactions

eFFECTOR Therapeutics Inc. (EFTR) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for EFTR

• 720d
  SEC Form 4 filed by Director Loewy Caroline M

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 720d
  SEC Form 4 filed by Director Klencke Barbara

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 720d
  SEC Form 4 filed by Director Ehrlich Christopher B

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 720d
  SEC Form 4 filed by Director Harrington-Smith Kristen

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 720d
  SEC Form 4 filed by Director Gallagher Brian M. Jr.

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 720d
  SEC Form 4 filed by Director Bhatt Elizabeth

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 747d
  Byrnes Michael was granted 1,387 shares, increasing direct ownership by 80% to 3,117 units (SEC Form 4)

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 747d
  Worland Stephen T was granted 1,806 shares, increasing direct ownership by 17% to 12,494 units (SEC Form 4)

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 833d
  SEC Form 4 filed by Loewy Caroline M

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 833d
  SEC Form 4 filed by Bhatt Elizabeth

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 833d
  SEC Form 4 filed by Ehrlich Christopher B

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 833d
  SEC Form 4 filed by Klencke Barbara

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 833d
  SEC Form 4 filed by Harrington-Smith Kristen

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 833d
  SEC Form 4 filed by Gallagher Brian M. Jr.

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 833d
  SEC Form 4 filed by Byrnes Michael

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 833d
  SEC Form 4 filed by Warner Douglas J

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 833d
  SEC Form 4 filed by Worland Stephen T

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 917d
  Sr One Capital Management, Llc sold $369,457 worth of shares (609,163 units at $0.61) (SEC Form 4)

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 930d
  Worland Stephen T was granted 5,979 shares, increasing direct ownership by 2% to 267,204 units (SEC Form 4)

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 930d
  Byrnes Michael was granted 4,524 shares, increasing direct ownership by 12% to 43,271 units (SEC Form 4)

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 996d
  SEC Form 4 filed by Loewy Caroline M

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 996d
  SEC Form 3: New insider Loewy Caroline M claimed ownership of 9,047 shares

  3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1024d
  SEC Form 4: Worland Stephen T exercised 33,799 shares at a strike of $0.52, increasing direct ownership by 15% to 261,225 units

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1077d
  SEC Form 4 filed by Smither John W

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1077d
  SEC Form 4 filed by Klencke Barbara

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1077d
  SEC Form 4 filed by Harrington-Smith Kristen

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1077d
  SEC Form 4 filed by Gallagher Brian M. Jr.

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1077d
  SEC Form 4 filed by Ehrlich Christopher B

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1077d
  SEC Form 4 filed by Bhatt Elizabeth

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1114d
  SEC Form 4 filed by Worland Stephen T

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1114d
  SEC Form 4 filed by Byrnes Michael

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1226d
  SEC Form 4 filed by Gallagher Brian M. Jr.

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1226d
  SEC Form 4 filed by Smither John W

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1226d
  SEC Form 4 filed by Harrington-Smith Kristen

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1226d
  SEC Form 4 filed by Klencke Barbara

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1226d
  SEC Form 4 filed by Ehrlich Christopher B

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1226d
  SEC Form 4 filed by Bhatt Elizabeth

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1231d
  SEC Form 4 filed by Worland Stephen T

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1231d
  SEC Form 4 filed by Warner Douglas J

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1231d
  SEC Form 4 filed by Gandhi Mayank

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1231d
  SEC Form 4 filed by Byrnes Michael

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1295d
  SEC Form 4: Byrnes Michael was granted 4,651 shares, increasing direct ownership by 16% to 33,884 units

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1295d
  SEC Form 4: Worland Stephen T was granted 6,047 shares, increasing direct ownership by 3% to 221,025 units

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1336d
  SEC Form 4: Ehrlich Christopher B bought $197 worth of shares (346 units at $0.57), increasing direct ownership by 0.99% to 35,213 units

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1344d
  SEC Form 4 filed by Gandhi Mayank

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1344d
  SEC Form 3 filed by new insider Gandhi Mayank

  3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1345d
  SEC Form 4: Ehrlich Christopher B bought $10,377 worth of shares (18,867 units at $0.55), increasing direct ownership by 118% to 34,867 units

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1392d
  SEC Form 3: New insider Carlyle Group Inc. claimed ownership of 4,822,114 shares

  3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1395d
  SEC Form 4 filed by Warner Douglas J

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1395d
  SEC Form 3 filed by new insider Warner Douglas J

  3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1400d
  SEC Form 4: Presidio Management Group X Llc sold $91,203 worth of shares (114,280 units at $0.80)

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1405d
  SEC Form 4: Presidio Management Group X Llc sold $29,005 worth of shares (32,517 units at $0.89)

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1407d
  SEC Form 4: Presidio Management Group X Llc sold $43,580 worth of shares (48,719 units at $0.89)

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1412d
  SEC Form 4: Presidio Management Group X Llc sold $19,514 worth of shares (20,309 units at $0.96)

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1415d
  SEC Form 4: Presidio Management Group X Llc sold $76,278 worth of shares (69,641 units at $1.10)

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1438d
  SEC Form 4: Gallagher Brian M. Jr. bought $47,700 worth of shares (30,000 units at $1.59)

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1442d
  SEC Form 4 filed by Mcnulty Alana B.

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1442d
  SEC Form 4 filed by Byrnes Michael

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1442d
  SEC Form 4 filed by Worland Stephen T

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1451d
  SEC Form 4 filed by Smither John W

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)